Entry of substrates into the multicatalyic 20S proteasome is regulated and stimulated by the 19S proteasome. Rpn11 and Rpn13 of the 19S proteasome, and three proteasome-associated proteins, Rad23, Dsk2, and Ddi1, serve as ubiquitin receptors (Finley, 2009 ). These latter proteins weakly bind to the proteasome and are termed UBL/UBA shuttle proteins due to their ubiquitin-like (UBL) and ubiquitin-associated (UBA) domains (Finley, 2009 ). Prior to degradation, the ubiquitin moieties must be removed and the protein substrates unfolded. Rpn11 in yeast (Poh1 in humans) serves as a deubiquitinating enzyme (DUB) in the presence of ATP and cooperates with two other deubiquitinases, Upb6 and Uch37 (Usp14 in mammals) (Finley, 2009) . Mammals possess about 90 known DUBs for cleaving polyubiquitin chains or for removing ubiquitin from protein substrates (Chen & Sun, 2009; Hofmann, 2009) . Although substrate unfolding and translocation are not completely understood, it is currently believed that the six ATPases of the 19S base unfold target proteins and open the gate of the 20S so that substrate proteins may reach the proteolytic sites (Finley, 2009; Shabek & Ciechanover, 2010) . Fig. 1 . Schematic representation of UPS-mediated protein regulation. A protein substrate (orange) is tagged with a polyubiquitin chain upon the activities of E1, E2, and E3 enzymes. Substrates modified by a K48-linked polyubiquitin chain are processed and degraded by the 26S proteasome, consisting of a 20S core and 19S regulatory particles. Oppositely, K63linkages are attributed to non-proteolytic functions and can allow for functional alterations of the tagged substrate.
The UPS and general repair proteins
Two proteins closely linked with DNA repair in general and regulated by the UPS are p53 and PCNA. In both cases, their UPS regulation can be either proteolytic or non-proteolytic (Coutts et al., 2009; Ulrich, 2009 ). p53 is regulated by the UPS in a way that prevents unnecessary cell death or cell-cycle arrest (Stehmeier & Muller, 2009 ). p53 interacts with the 19S proteasome in vitro and in vivo (Zhu et al., 2007) and can be both mono-or polyubiquitinated (Stehmeier & Muller, 2009 ). Mdm2, a ubiquitin-protein ligase, promotes the ubiquitination and consequent degradation of p53 as well as the conjugation of NEDD8 (Zhang & Xiong, 2001; Xirodimas et al., 2004) . NEDD8 conjugation appears to weaken the inhibition of p53, and this ubiquitination and NEDDylation of p53 are independently regulated upon DNA damage (Xirodimas et al., 2004) . Additionally, both p53 and Mdm2 are modified by SUMO-1 . Only a small fraction of p53 is sumoylated, and the possible role of p53 sumoylation in degradation and DNA repair is still being investigated (Stehmeier & Muller, 2009) . Similarly, proliferating cell nuclear antigen (PCNA), a processivity clamp for the replicative and repair DNA polymerases, is a target of the UPS (Paunesku et al., 2001; Ulrich, 2009 ). In yeast, PCNA is modified by SUMO at the beginning of S-phase (Papouli et al., 2005; Pfander et al., 2005) ; however, in response to DNA damage, PCNA is monoubiquitinated in a Rad6/Rad18 dependent manner (Hoege et al., 2002; Lee & Myung, 2008) . Further modification with a K63-linked polyubiquitin chain can then occur pending the interaction of Rad5, a ubiquitin-protein ligase, and Ubc13-Mms2, a ubiquitin-conjugating dimer (Hofmann, 2009 ). Monoubiquitinated and polyubiquitinated PCNA proteins are involved in different DNA repair mechanisms. Proteins PTIP/Swift, an adapter for checkpoint kinases ATM and ATR, and ubiquitin specific protease 1 (USP1) deubiquitinate PCNA Ulrich, 2009 ). Finally, tight regulation of PCNA ubiquitination, keeping ubiquitinated PCNA at low levels in undamaged cells, prevents the recruitment of translesion synthesis (TLS) polymerases, an event that could lead to mutagenesis (Lee & Myung, 2008) . For more on PCNA, see section 7.
Nucleotide excision repair
Nucleotide excision repair (NER) is an evolutionarily conserved, multistep mechanism responsible for removing bulky chemical adducts and UV-induced photoproducts from DNA (Sharova, 2005a) . NER can be divided into repair of overall genomic DNA [global genome repair (GGR)] and repair of actively transcribing genes [transcription-coupled repair (TCR)] (Mueller & Smerdon, 1996) . Approximately 30 proteins participate in NER. In this relatively error-free repair process, sites of DNA damage are first recognized and bound by a multi-protein complex. The damaged strand is then cleaved several nucleotides away from the 5' and 3' ends of the affected oligonucleotide. Upon removal of this fragment, the resulting ~30 nucleotide gap is filled by DNA polymerases and in a PCNA-dependent manner, and a DNA ligase covalently attaches the 3' end of the newly synthesized strand to the flanking DNA (Lommel et al., 2000) . Defects in NER are associated with diseases such as Xeroderma Pigmentosum, Cockayne's Syndrome, and Trichothiodystrophy (Bergoglio & Magnaldo, 2006; Leibeling et al., 2006) .
Nucleotide excision repair enzymes and the UPS
In mammalian cells, the first step of NER initiation after damage involves the Damaged-DNA binding protein (DDB) complex that recognizes sites of complex adducts, including those induced by UV radiation (Stoyanova et al., 2009; Iovine et al., 2011) . Two protein members of this complex, DDB1 and DDB2, associate with the Cullin 4A (Cul4A) ubiquitin E3 complex, which has been shown to polyubiquitinate Xeroderma pigmentosum C protein (XPC) (Stoyanova et al., 2009; Iovine et al., 2011) . DDB1 regulates cyclin-dependent kinase inhibitor 1B (p27) levels after low-dose UV irradiation (Iovine et al., 2011) . DDB2 associates with COP9 Signalosome complex (CSN), which has structural homology to the 19S proteasome (Groisman et al., 2003) . DDB2 also regulates levels of cyclin-dependent kinase inhibitor 1 (Cip1 or p21) and phospho-p53 through the UPS (Stoyanova et al., 2009) . Interestingly, DDB2 is targeted by Cul4A and polyubiquitinated after UV irradiation (Bergink et al., 2007; Stoyanova et al., 2009; Iovine et al., 2011) . Therefore, both DDB2 and XPC are downregulated by Cul4A, but protein degradation in this situation promotes a www.intechopen.com DNA Repair − On the Pathways to Fixing DNA Damage and Errors 260 more efficient DNA repair, as explained further later. No homolog of DDB2 is found in yeast, but a comparable E3 enzyme complex containing Rad16, Rad7, Cul3, and Elc1 is linked to GGR in yeast (Gillette et al., 2006; Dantuma et al., 2009) . Following UV irradiation, ubiquitin and SUMO-1 modify XPC in a manner dependent on DDB2 and XPA (Wang et al., 2005b) . XPC in mammalian cells and Rad7 and Rad16 in yeast are required for GGR . Cockayne syndrome complementation group A and B proteins (CSA and CSB) in mammals and Rpb9 and Rad26 (the homologue of CSB) in yeast are required for TCR . CSA and CSB are also necessary for ubiquitination of Rpb1, the largest subunit of RNA polymerase II (Pol II) . When DNA damage causes DNA Polymerase II to become stalled, Rpb1 is polyubiquitinated and degraded by the 26S proteasome (Ribar et al., 2006; Chen et al., 2007) . It does not appear as if the whole Pol II complex is degraded (Ribar et al., 2006) , and Rpb9, another subunit of Pol II, mediates the ubiquitination of Rpb1 in response to UV radiation Daulny & Tansey, 2009 ). Conversely, the DUB Ubp3 deubiquitinates Pol II and prevents its degradation (Mao & Smerdon, 2010) . Different types of histone modifications are associated with DNA repair, such as monoubiquitination of histone H2A following UV-damage (Bergink et al., 2006) . Ubiquitinated H2A (uH2A) is the most common modification of histones in higher eukaryotes, and uH2A foci formation requires either functional GGR or TCR (Zhu et al., 2009) . The E3 enzyme Cul4A-DDB has also been shown to ubiquitinate histones H3 and H4 in order to positively regulate NER (Zhu et al., 2009) . Histone ubiquitination could play a role in chromatin remodelling and is dependent on RING2, an E3 enzyme, and ATR-kinase (Bergink et al., 2006) . The pivotal yeast NER protein Rad4, the yeast homologue of XPC, is involved in this process. Rad4 binds to Snf5 and Snf6 of the Swi/Snf chromatin-remodelling complex (Gong et al., 2006) , which correlates with UV-induced chromatin remodelling; this event could induce DNA to be more accessible to repair proteins (Dantuma et al., 2009) . Interestingly, proteasome inhibitors such as lactacystin (LC) and N-acetyl-leucyl-leucylnorleucinal (ALLnL) deplete free cellular ubiquitin, thereby negatively affecting protein dynamics of histones, and promote chromatin condensation (Mimnaugh et al., 2000) . Yeast protein Rad23 is involved in both NER pathways: GGR and TCR (Mueller & Smerdon, 1996) . Rad23 itself is not degraded by the 26S proteasome because it lacks an initiation region for the proteasome to engage and unfold it (Fishbain et al., 2011) . However, Rad23 has been shown to contact proteins Rpt1 (Cim5), Rpt4 (Sug2), Rpt6 (Cim3/Sug1), Rpn1, and Rpn10 (S5a) of the 19S proteasome (Waters et al., 1993; Motegi et al., 2009 ), perhaps to recruit it to sites of DNA damage (Russell et al., 1999) . The N-terminal domain of Rad23 (the UbL domain) resembles ubiquitin, which enables it to interact with the 26S proteasome directly (Watkins et al., 1993; Schauber et al., 1998) . Notably, Rad23 has 22% identical and 43% similar amino acid residues compared to ubiquitin from S. cerevisiae (Watkins et al., 1993; Schauber et al., 1998) . Deletion of the UbL domain impairs Rad23 function, leading to UV-sensitivity and a 50% decrease of NER activity in yeast (Watkins et al., 1993; Russell et al., 1999) . This effect is reversed, however, upon substitution of the UbL domain with the sequence of ubiquitin (Watkins et al., 1993) . E1-ubiquitin and E2-ubiquitin thioester intermediate formation does not appear to be affected by Rad23, but the presence of Rad23 remarkably stabilizes proteins in vivo and inhibits multi-ubiquitin chain assembly in vitro (Ortolan et al., 2000) . The two UBA regions of Rad23 participate in noncovalent interactions with ubiquitin, and loss of both UBA regions does not allow Rad23 to block assembly of multi-ubiquitin chains on protein substrates . Interestingly, the C-termini of the human homologues to Rad23, hHR23A and hHR23B, contain a stretch of amino acids homologous to E2 enzymes (van der Spek et al., 1996; Masutani et al., 1997) . The C-terminus of Rad23 binds with high affinity to Rad4 (Mimnaugh et al., 2000) . Rad23/Rad4 complexes govern damage recognition and bind UV-irradiated DNA (Guzder et al., 1998; Jansen et al., 1998; Guzder et al., 1999) ; loss of Rad4 leads to severe UVsensitivity (Ortolan et al., 2000) . Rad23 can regulate polyubiquitination of Rad4 in vivo and delay its degradation by the 26S proteasome (Lommel et al., 2002) . The Rad4 binding domain (R4B) of Rad23 is also sufficient to stabilize Rad4 and enable NER in yeast strains lacking Rad23 (Ortolan et al., 2004) . Nevertheless, in a Rad23 null strain, overexpression of Rad4-hemagglutinin does not rescue the impaired repair of cyclobutane pyrimidine dimers (CPDs) (Lommel et al., 2002) . Rad23 may protect Rad4 from degradation so that it can participate in NER, but Rad23 may also play proteolytic roles in other pathways (Ortolan et al., 2004) . Essentially, optimal NER necessitates two distinct functions of Rad23; both Rad23/proteasome and Rad23/Rad4 interactions are required for maximum UV-resistance (Ortolan et al., 2004) . Other yeast enzymes, Rad7 and Rad16, are also involved in UPS regulation of NER. These proteins are members of the nucleotide excision repair factor 4 (NEF4) complex, which bears E3 activity and regulates Rad4 levels (Ramsey et al., 2004) . The DUB Upb3 promotes degradation of Rad4, which leads to a negative regulation NER; conversely, inactivation of Upb3 stabilizes Rad4 (Mao & Smerdon, 2010) . Ubiquitination is necessary for NER, since E1 enzyme inactivation exerts a negative influence on NER in mammalian cells (Wang et al., 2005a) . However, much debate surrounding NER and the UPS still exists, revolving around the question of whether UPSmediated modifications leading to proteolysis (a proteolytic role of the UPS) are more or less important for NER than the modifications (ubiquitination, sumoylation, etc.) that do not lead to protein degradation (a non-proteolytic role of the UPS). For example, Rad23 is not degraded by the proteasome, and this suggests that it has a non-proteolytic role (Watkins et al., 1993) . Antibodies against the ATPases of the 19S have been shown to measurably lower NER activity, but mutations in 20S subunits that severely curb proteolysis and incubation with proteosome inhibitor LC do not appear to change NER activity (Russell et al., 1999; Gillette et al., 2001) . Also, efficient NER in yeast relies on two mechanisms related to the necessity of de novo protein synthesis, neither of which entails proteolytic behavior (Gillette et al., 2006) . Rad23 and the 19S proteasome regulate one such pathway, independently of de novo protein synthesis. Another pathway involving Rad4 ubiquitination by a Rad7containing E3 ligase depends on de novo protein synthesis to restore Rad4 to baseline levels such as they were prior to DNA damage (Gillette et al., 2006) . All these findings stress a connection between NER and non-proteolytic behavior of the UPS (Gillette et al., 2006) . However, NER has been shown to be increased in yeast strains with mutations in genes encoding the 26S proteasome (Lommel et al., 2002) . Proteosome inhibitors LC and ALLnL interfere with removal by NER of cisplatin-damaged DNA and decrease mRNA levels of the excision nuclease Ercc-1 in ovarian cancer cells (Mimnaugh et al., 2000) . Treatment of normal human fibroblasts with proteosome inhibitors MG132 or LC decreases repair of CPDs (Wang et al., 2005a) . Overexpression of hSug1, one of the six ATPases of the mammalian 19S proteasome, competes with endogenous 19S proteasomes for substrates and negatively affects NER (Wang et al., 2005a) . In yeast, conditional proteasome mutants of Rpt1 and Rpt6 exhibit faster NER in a single gene repair study (Lommel et al., 2000) . Similarly, overexpression of Rad4 results in increased NER of the transcribed and non-transcribed strands of the damaged gene. Therefore, proteosome subunit overexpression has an effect similar to overexpression of the NER protein Rad4, which results in increased GGR and TCR (Lommel et al., 2000) . Ultimately, this apparent discrepancy could stem from the use of different model systems because NER proteins and processes differ among different organisms (Wang et al., 2005a) . The exact role(s) of the 26S proteasome in NER remain somewhat obscured. There is no consensus on whether the 26S proteasome plays excitatory and/or inhibitory roles in NER, nor is the balance between the roles of Rad23 in DNA repair and proteolysis fully understood (Dantuma et al., 2009) . It is unclear whether Rad23 is ubiquitinated itself, and if so, what is the significance of that modification (Dantuma et al., 2009 ). Nevertheless, evidence of "protein sharing" between the UPS and NER suggests a functional connection that is deeper than our present understanding of this system.
Base excision repair
The base excision repair (BER) pathway regulates removal of damaged bases, apurinic/apyrimidinic (AP) sites, and single-strand breaks (SSBs) induced by UV radiation, ionizing radiation, oxidative stressors, and alkylating agents (Dalhus et al., 2009; Wilson et al., 2010) . For every double-stranded DNA break (DSB), cells sustain hundreds of SSBs; consequently, BER activity in cells is perpetually engaged. BER can be separated into longpatch repair and short-patch repair, dependent upon the type of lesion incurred as well as the expression levels of BER proteins (Memisoglu & Samson, 2000; Wilson et al., 2010) . The most fundamental steps of BER include damaged base recognition and removal by DNA glycosylases, strand cleavage by an AP endonuclease, incised strand processing, DNA synthesis, and ligation (Sharova, 2005a) . Processing of gaps in mammalian DNA involves a DNA polymerase (primarily Pol ), DNA ligase III , and X-ray crosscomplementing group-1 protein (Xrcc1) (Parsons et al., 2010) . Importantly, the BER, NER, and MMR activities can overlap in protection against DNA damage (Wilson et al., 2010) , sharing proteins such as Rad4. Dysfunctional BER can lead to chromosomal rearrangements and cell death, and defects/knock-out animals for BER genes are often associated with embryonic lethality (Wilson & Thompson, 1997) .
Base excision repair and the UPS
While poly (ADP-ribose) polymerase-1 (PARP-1) does not appear to play an enzymatic role in BER, it is the molecule that recognizes DNA damage repaired by BER. Moreover, PARP inhibition delays repair of SSBs in Xrcc1-deficient cells and protects SSBs from becoming DSBs, thereby ensuring that the SSBs may be repaired by BER proteins (Woodhouse et al., 2008) . PARP-1 has been shown to be polyubiquitinated and modified by SUMO-1 and SUMO-3 in vitro and in vivo (Wang et al., 2008; Messner et al., 2009 ). Polyubiquitination of PARP-1 requires proteasomal inhibition, indicating that it is a target of the 26S proteasome (Wang et al., 2008) . In a yeast two-hybrid screen, PARP was found to interact with hUbc9, the human protein homologous to Ubc9, a yeast E2 enzyme (Masson et al., 1997) . hUbc9 mRNA has been shown to increase at the beginning of S-phase, suggesting that hUbc9 is involved in degradation of cyclins, as Ubc9 is in yeast (Masson et al., 1997) . The transcription of yeast DNA glycosylase genes MAG1, NTG1, and NTG2 is co-regulated with proteasomal genes and modulated by transcription factor Rpn4, a negative regulator of the proteosome (Jelinsky et al., 2000; Hanna & Finley, 2007) . Another BER DNA glycosylase, thymine-DNA glycosylase (TDG), binds SUMO-1 covalently and noncovalently (Takahashi et al., 2005) . Covalent modification of TDG with SUMO-1 or SUMO-3 reduces its affinity for DNA (Hardeland et al., 2002b) . The enzymatic properties of TDG change upon sumoylation; G•T mismatch processing is repressed, whereas G•U processing augments. TDG sumoylation facilitates its dissociation from AP sites, allowing for AP endonuclease entry (Hardeland et al., 2002b) . Mechanistically, TDG changes conformation when it contacts DNA, binding tightly to mismatches; conjugation of SUMO-1 to the C-terminal domain of TDG induces another conformational change in the N-terminus of TDG so that it can dissociate from the AP sites (Steinacher & Schar, 2005b) . TDG sumoylation does not seem to affect polyubiquitination and degradation of TDG (Hardeland et al., 2007) . While TDG levels are highest during G2/M-and G1-phases of the cell-cycle but taper during S-phase, UNG2, a uracil-DNA glycosylase, is upregulated during S-phase (Hardeland et al., 2007) . Thus, TDG and UNG2 play non-redundant, alternating roles. The UPS regulates these precise fluctuations in TDG and UNG2 protein levels; for example, treatment with the proteasomal inhibitor MG132 measurably increases TDG levels (Hardeland et al., 2007) . Interestingly, a key role of ubiquitination in BER is to modify the proteins that are not members of an active BER complex so that they may be rapidly degraded, which allows clearance of access for BER proteins. CHIP, an E3 enzyme, is responsible for turnover of BER proteins such as Xrcc1, which acts as a scaffold for directing assembly of BER complexes at sites of DNA damage, and Pol  (Parsons et al., 2008b) . Although CHIP appears to be the principal E3 in this process, other E3 enzymes may be involved as well. Phosphorylation of Xrcc1 by casein kinase 2 (CK2) appears to be necessary for efficient BER; this phosphorylation improves the stability of Xrcc1 by protecting it from ubiquitination (Parsons et al., 2010) . In addition, Xrcc1 recruits JWA to sites of damage, and loss of JWA leads to Xrcc1 degradation by the UPS (Wang et al., 2009) . Xrcc1 is also modified by SUMO-1 (Gocke et al., 2005; Moschos & Mo, 2006) .
Mismatch repair
The mismatch repair (MMR) system corrects noncomplementary base pairs that escape the proofreading activity of DNA polymerases and in DNA replication (Jiricny, 1998; Sharova, 2005b) . The process begins with mispair recognition by the hMutS complex, a heterodimer of hMSH2 and hMSH6, or by the complex hMutS , a heterodimer of hMSH2 and hMSH3 (Modrich & Lahue, 1996; Jiricny, 1998; Kolodner & Marsischky, 1999) . Another complex, hMutL , a heterodimer of hMLH1and hPMS2, regulates the termination of mismatch-stimulated DNA excision (Li, 2008) .
Mismatch repair and the UPS
The UPS is involved in post-transcriptional regulation of hMutS protein expression (Humbert et al., 2002; Hernandez-Pigeon et al., 2004) . Ubiquitination and degradation rates of hMSH2 and hMSH6 appear quite similar, suggesting that UPS-mediated proteolysis may maintain a constant ratio of these two proteins (Hernandez-Pigeon et al., 2004) . While no strong correlation between total proteasomal activity and the degradation rate of hMutS has been observed in vitro, low hMutS expression in cells is a limiting factor for MMR and indicative of proteolytic activity of the UPS in MMR regulation (Ciechanover, 1994; Humbert et al., 2002; Hernandez-Pigeon et al., 2004) . This process is regulated also by an atypical protein kinase C (PKC ); this kinase increases hMutS protein levels and the binding of hMutS to G•T mismatches (Hernandez-Pigeon et al., 2005) . Essentially, PKC expression and ubiquitination of hMutS proteins are inversely related, and PKC kinase activity interferes in the UPS-mediated degradation of hMutS (Hernandez-Pigeon et al., 2005) . Collectively, these results support a model in which PKC serves as a positive regulator for UPS-mediated MMR by directly interacting with the hMutS complex. There is also evidence of hMutS protein sumoylation, but the functional importance of this is unclear (Hernandez-Pigeon et al., 2005) . Human exonuclease I (hEXO1) complexes with hMutL and functions in the excision step of MMR (Schmutte et al., 2001; Genschel et al., 2002) . In response to DNA replication arrest, the isoform hEXO1b is polyubiquitinated and degraded, and phosphorylation of hEXO1b correlates with its UPS-mediated degradation (El-Shemerly et al., 2005 ).
Double-strand break repair
DNA double-strand breaks (DSBs) can be lethal to cells predominantly because the most important DSB repair process, non-homologous end joining (NHEJ), is error-prone, leaving mutations in the DNA following repair. Two possible repair processes that correct DSBs are homologous recombination (HR) and NHEJ. HR repair exchanges nucleotide sequences between two homologous chromosomes; this leads to error-free repair of DSB damage, preventing mutagenesis . During the initial stages of mammalian HR, the MRN complex, composed of Mre11-Rad50-Nbs1, recognizes and carries out initial processing of the broken DNA ends. Following DSB resection, single-stranded DNA ends are bound by Rad51, Rad52, and RPA . Strand invasion and displacement to initiate repair synthesis from the homologous sequence are mediated by Rad51, Rad54, Brca1, and Brca2, and HR is completed upon DNA annealing and ligation (Li & Heyer, 2008) . NHEJ is a rapid, error-prone pathway that does not necessarily restore the sequence around the DSB, leading to local deletions and chromosomal translocations. NHEJ is the predominant form of DSB repair in mammalian cells because it occurs in the G0-, G1-, and early S-phases of the cell-cycle (before duplication of the DNA). The Ku70/Ku80 heterodimer detects the exposed ends of DNA DSBs in NHEJ and then recruits and forms a holoenzyme with DNA-dependent protein kinase (DNA-PK) to sense and to repair damaged DNA (Gottlieb & Jackson, 1993; Downs & Jackson, 2004) . The MRN complex also influences NHEJ, and Xrcc4 and ligase IV complete the resealing reaction.
Double-strand break repair and the UPS
Crosslinking and chromatin immunoprecipitation studies reveal that subunits of the 26S proteasome are recruited to DSB sites, suggesting that proteolysis takes place concurrent with DSB repair (Krogan et al., 2004) . Both NHEJ and HR are affected by interaction with the proteasome, such as through DNA polymerase IV (Pol4) and Rad52, respectively (Tseng & Tomkinson, 2002; Krogan et al., 2004) . Rad52 forms multimeric ring foci, which are centers of recombination repair capable of processing multiple DNA lesions (West, 2003) . Other HR proteins depend on the presence of Rad52 and its interaction with ssDNA regions in HR repair for their function (West, 2003) . In yeast, one of the proteins associated with Rad52 is Sem1, a component of the yeast 19S proteasome. In the absence of Rad52, recruitment of Sem1 to damaged DNA is reduced (Krogan et al., 2004) . Moreover, knock-out of Sem1 in yeast strains capable of only HR or NHEJ, but not both, results in impaired cell growth. Therefore, Sem1 and the proteasome are crucial for HR DSB repair (Krogan et al., 2004) . The human homolog of Sem1, Deleted in Split hand/Split foot 1 (DSS1), is a part of the human 19S proteasome and involved in HR through interaction with Brca2 (Marston et al., 1999) . Just as knock-out of Brca2 increases dependence of HR on mammalian Rad52 (West, 2003) , depletion of DSS1 in human cells significantly reduces HR activity, while treatment with proteasome inhibitors corresponds to a smaller decrease in HR (Kristensen et al., 2010) . Thus, it is likely that DSS1 engages in functions in HR other than strictly proteolysis (Kristensen et al., 2010) . DSS1 and Brca2 interact with Rpn3 and Rpn7, though the Brca2/Rpn7 interaction does not depend on DSS1 (Gudmundsdottir et al., 2007) . On the contrary, it is Brca2 that secures the presence of the proteasome close to DNA repair machinery. Upon treatment of an ES cell line with the proteasome inhibitor epoxomicin, Gudmundsdottir and colleagues observed a shift in the repair of repetitive elements from the error-free gene conversion pathway to the error-prone single-strand annealing pathway. This suggests that the proteasome plays a functional role in support of HR as a repair mechanism of DSBs (Gudmundsdottir et al., 2007) . As mentioned previously, knock-out of different proteasomal subunits or proteosome inhibition by small molecules interferes with both HR and NHEJ in yeast (Krogan et al., 2004) ; in higher eukaryotes, association of NHEJ and proteosome appears to be less obligatory. Here, proteasome inhibitors MG132 and LC reduce HR-dependent DSB repair but only marginally affect NHEJ-mediated repair of an artificial substrate . MG132 treatment of Ku70-deficient chicken DT40 cells, which are impaired in NHEJ but not in HR, negatively affects the repair kinetics of ionizing radiation-induced DSBs. However, MG132 treatment of Rad54-deficient chicken DT40 cells, impaired in HR but not in NHEJ, does not delay DSB repair. Ionizing radiation-induced Brca1 and Rad51 foci formation in HeLa cells is reduced upon treatment with MG132. Therefore, it appears as if the proteasome functions at an early step of HR, prior to formation of the Brca2-DSS1 complex . Brca1 contains a RING domain, which is generally associated with ubiquitin-protein ligase activity (Starita & Parvin, 2003) . Human C-terminal binding protein interacting protein (CtIP), which regulates DSB resection and efficient HR, is ubiquitinated when it associates with chromatin following DNA damage. This ubiquitination of CtIP is catalyzed by Brca1 and is not a degradation signal Sartori et al., 2007) . Brca1 dimerizes with Bard1 to elicit higher ubiquitin-protein ligase activity than either Brca1 or Bard1 alone (Hashizume et al., 2001; Xia et al., 2003) . These two proteins appear to stabilize one another in vivo, suggesting that each does not participate in the degradation of the other (Hashizume et al., 2001; Xia et al., 2003) . Brca1/Bard1 assemble polyubiquitin chain linkages through non-K48 residues, mostly through K63, indicative of non-proteolytic function . The Brca1/Bard1 complex is capable of autoubiquitination in vitro and in vivo, and it also mediates monoubiquitination of histone H2A/H2AX in vitro . At a higher level of complexity, Brca1/Bard1, Rap80, which has two domains that bind K63linked ubiquitin chains, the DUB Brcc36, and Abraxas form a complex that localizes to damaged DNA (Wang & Elledge, 2007) . Ubc13, an E2 enzyme, and Rnf8, a Ubc13-associated E3 enzyme, which together catalyze K63-linked ubiquitin chains at DSBs, are both required for Rap80 and Abraxas foci formation induced by ionizing radiation (Huen et al., 2007; Kolas et al., 2007; Wang & Elledge, 2007) . The interaction between Rap80 and Abraxas localizes Brca1 and the DUB Brcc36 to ionizing radiation-induced foci (Wang & Elledge, 2007) .
In conducting studies revolving around the sensitivity of Ubc13-deficient cells to DNAdamaging agents, Zhao and co-workers discovered a link between Ubc13 and HR in higher eukaryotes. Mammalian cells depleted of Ubc13 demonstrate defective HR following ionizing radiation . This observation corresponds with impaired recruitment of Rad51 to DSBs, reduced Brca1 ubiquitin-protein ligase activity and foci formation, and decreased accumulation of RPA single-strand binding protein at DNA lesions. NHEJ, however, appears to function normally in Ubc13 null cells. The role of Ubc13 in HR does not appear to involve PCNA ubiquitination, thereby distinguishing the role of Ubc13 in HR from its activities in post-replication repair (PRR). Nevertheless, the mechanism of Ubc13-promoted DSB resection requires further investigation . The E3 ubiquitin-protein ligase, Rnf8, a modulator of the DNA damage response, mediates histone ubiquitination and allows DSB-flanking chromatin to accumulate additional DNA damage regulators (Huen et al., 2007; Kolas et al., 2007; Mailand et al., 2007; Wang & Elledge, 2007; Doil et al., 2009 ). In particular, Rnf8 is required for accumulation of 53BP1 and Brca1 following ionizing radiation (Huen et al., 2007; Kolas et al., 2007; Mailand et al., 2007; Sakasai & Tibbetts, 2008) . Following UV illumination, recruitment of 53BP1 partially depends on Ubc13 and Rnf8, and 53BP1 recruitment is suppressed upon proteasomal inhibition (Sakasai & Tibbetts, 2008) . Importantly, 53BP1-deficient cells exhibit defects in NHEJ (Nakamura et al., 2006) . Rnf8 is the first E3 to assemble at DSBs and allows for the recruitment of another E3 ligase, Rnf168, which has two ubiquitin-binding domains. Rnf168 appears to increase K63-linked ubiquitination at DSBs necessary to retain 53BP1 and Brca1 (Doil et al., 2009 ). Stewart and co-workers identified Rnf168 as the gene mutated in RIDDLE Syndrome (Stewart et al., 2009 ), a disorder characterized in part by radiosensitivity and immunodeficiency. Cells derived from a RIDDLE patient fail to localize 53BP1 to DSBs (Stewart et al., 2007) . Accordingly, these cells display decreased Brca1 foci formation, hypersensitivity to ionizing radiation, and irregular cell-cycle checkpoints (Stewart et al., 2007; Stewart et al., 2009) . With regard to UBLs, SUMO-1 is the most frequently involved in DSB repair; it forms stable complexes with Rad51, Rad52, and Rad51/Rad52 in co-immunoprecipitation experiments (Shen et al., 1996; Li et al., 2000) . The role of SUMO-1 in HR appears to be inhibitory, as overexpression of SUMO-1 has been shown to measurably decrease radioresistance and bidirectional gene conversion tracts in mammalian cells . Sumoylation of Rad52 is observed infrequently unless this modification of Rad52 is induced in a cell cycleand lesion-specific fashion (Ohuchi et al., 2008) . In yeast, Rad52 sumoylation appears to be triggered specifically by interactions with Rad50, Mre11 and Xrs2 (but not Rad51), members of the yeast homolog of the MRN complex, the MRX complex (Sacher et al., 2006; Ohuchi et al., 2008) . There is conflicting evidence pertaining to the residues required for Rad52 sumoylation, but self-association of Rad52 appears important for its sumoylation. Essentially, sumoylation of Rad52 appears to preserve Rad52 activity and to inhibit rapid degradation of the protein (Sacher et al., 2006) . Two of the key NHEJ enzymes, Ku70 and Ku80, are susceptible to ubiquitination (Gama et al., 2006) . Ku70 and Ku 80 are degraded by the proteasome, and MG132 delays proteolysis of these proteins (Postow et al., 2008; Enokido et al., 2010) . Ubiquitinated Ku70 in human cells has been detected in the absence of proteasome inhibitors, indicating that this modification may not always serve as a degradation signal for Ku70; yet, apoptotic stress does upregulate degradative Ku70 ubiquitination (Gama et al., 2006) . Ku70 and Ku80 stabilize one another, but ubiquitinated Ku70 appears to inhibit Ku70/Ku80 complex formation (Gama et al., 2006) . Ku80 is polyubiquitinated when bound to DSBs in Xenopus laevis egg extracts, and this K48-linked polyubiquitination is related to removal of Ku80 from DNA (Postow et al., 2008) . However, polyubiquitination-induced removal of Ku80 from DSBs is not required for the completion of NHEJ (Postow et al., 2008) . In yeast, aberrant expression of key proteosome regulating transcription factor Rpn4 appears to hinder NHEJ but not HR (Ju et al., 2010) . When proteosomal degradation of Rpn4 itself is inhibited, the expression levels of Ku70, Ku80, and Mre11 are decreased, as well as the accumulation of Ku70 at DSBs (Ju et al., 2010) . Ubiquitination and levels of monoubiquitinated Xrcc4 increase upon etoposide-induced DNA damage (Foster et al., 2006) . Xrcc4, however, is a stable protein, and treatment with proteasome inhibitors does not correlate with Xrcc4 accumulation, suggesting that this type of Xrcc4 modification serves a non-proteolytic function. This enzyme also stabilizes ligase IV, whose half-life also increases upon treatment with proteasome inhibitors (Foster et al., 2006) . Human Xrcc4 is also sumoylated in vitro and in vivo (Yurchenko et al., 2006) . This modification regulates Xrcc4 localization; a non-sumoylated mutated Xrcc4 protein accumulates in the cytoplasm rather than in the nucleus (Yurchenko et al., 2006) . This mutant protein causes radiosensitivity, but fusion of SUMO to its C-terminus leads to nuclear Xrcc4 localization and radiation resistance of cells with this genotype (Yurchenko et al., 2006) .
Post-replication repair
Post-replication repair (PRR), also known as DNA damage tolerance or damage bypass, is a process that fills gaps formed in newly synthesized single-stranded DNA. This type of repair is essential for avoiding unrepaired DSBs, such as those tha t r e s u l t f r o m t h e prolonged stalling of DNA replication forks (Podlaska et al., 2003; Zhuang et al., 2008) . PRR operates by either an error-free or an error-prone mechanism. The error-free/damage avoidance pathway involves HR or template switching to the undamaged sister chromatid (Lee & Myung, 2008; Ulrich, 2009 ). The error-prone method, referred to as DNA translesion synthesis (TLS), is carried out by a TLS polymerase such as Pol , Pol , Pol , Pol , or Rev1 (Prakash et al., 2005) . Rad6, an E2 enzyme, and Rad18, a DNA-binding protein, form a complex that governs PRR and is responsible for PCNA modification, a crucial event in this DNA repair pathway (Hoege et al., 2002; McIntyre et al., 2006) .
Post-replication repair and the UPS
Proteasome inhibitors have been shown to disrupt TLS in cancer cells by delaying cisplatin and UV-induced translesion reactions (Takezawa et al., 2008) . Studies of defective 20S proteasomal activity in yeast strains have revealed important relationships between the UPS and PRR. The Ump1 proteasomal maturase is required for processing of the -subunits and proper assembly of the 20S proteasome (Ramos et al., 1998) . Deletion of Ump1 or of the genes encoding the 2-and 5-subunits of the 20S proteasome, Pup1 and Pre2, respectively, correlates with an increase in UV-sensitivity and spontaneous mutagenesis. Importantly, this phenotype is characteristic of yeast strains with defects in PRR, and Podlaska and colleagues have determined that these genes are members of the Rad6/Rad18 epistasis group (Podlaska et al., 2003) . This spontaneous mutator phenotype has been verified to be primarily PRR-based and unrelated to the HR and NER pathways (McIntyre et al., 2006) .
Knock-out of Rev3, which encodes the catalytic subunit of Pol , in an Ump1-deficient yeast strain correlates with a dramatic decrease in the frequency of UV-induced and spontaneous mutations, thereby suggesting that Ump1 may serve as a negative regulator of Rev3 (Podlaska et al., 2003; McIntyre et al., 2006; Wiltrout & Walker, 2011) . In contrast, the presence of Rad30, which encodes Pol , in an Ump1-deficient background is associated with increased UV-sensitivity but a decrease in the frequency of spontaneous mutations (Podlaska et al., 2003; McIntyre et al., 2006) . Taken together, these results suggest that Rev3 and Rad30 are epistatic to Ump1 and that mutations caused by proteasomal defects depend upon both Pol and Pol (Podlaska et al., 2003; McIntyre et al., 2006) . Rad30 is a short-lived protein post-translationally regulated by the UPS (Skoneczna et al., 2007) . Its degradation depends on the Skp1/Cullin/F-box E3 enzyme complex and the Ufo1 F-box protein (Skoneczna et al., 2007) . Rev1 is also a relatively short-lived protein but has a longer half-life during G2/M-phases than G1-phase, potentially implicating proteasomal regulation. In support of this idea, Rev1 levels are elevated upon treatment with proteasome inhibitors or in an Ump1-deficient background (Wiltrout & Walker, 2011) . Ubiquitin is essential for the regulation, localization, and stability of Rad18 PRR protein (Ulrich, 2009) . In response to DNA damage, Rad18 autoubiquitination indirectly regulates PRR by balancing levels of unmodified Rad18 in the nucleus and monoubiquitinated Rad18 in the cytoplasm (Miyase et al., 2005) . Polyubiquitinated Rad18 is not present under normal conditions, potentially because it is subject to rapid degradation. However, polyubiquitinated Rad18 may be detected upon treatment with proteasome inhibitors or in an in vitro system consisting of Rad18, one E1 enzyme, Rad6, and ubiquitin (Miyase et al., 2005) . Rad18 also influences PCNA monoubiquitination following DNA damage (Hoege et al., 2002; Stelter & Ulrich, 2003; Kannouche et al., 2004) . Monoubiquitinated PCNA is thought to promote the error-prone TLS pathway, while polyubiquitinated PCNA may regulate the error-free damage avoidance pathway (Hoege et al., 2002; Stelter & Ulrich, 2003; Kannouche et al., 2004; Watanabe et al., 2004) . Monoubiquitinated PCNA is thought to facilitate targeting of Pol to DNA damage sites and is required for the replacement of stalled Pol by Pol (Kannouche et al., 2004; Watanabe et al., 2004; Zhuang et al., 2008) . In response to DNA damage, Pol and Pol also noncovalently interact with ubiquitin and monoubiquitinated PCNA (Bienko et al., 2005; Plosky et al., 2006) . Pol and Pol mutants lacking the ability to bind ubiquitin demonstrate downregulated levels of DNA damageinduced replication foci; this suggests that the polymerase-ubiquitin interaction may be an important component in the recruitment of TLS polymerases to stalled replication forks (Plosky et al., 2006) . Ubiquitinated PCNA also substantially activates Pol and Rev1 in vitro . Unmodified PCNA stimulates Pol -mediated TLS, and no significant differences in this type of TLS are observed upon substitution of unmodified PCNA with ubiquitinated PCNA . Thus, ubiquitinated PCNA has different functional interactions with the various TLS polymerases. Importantly, it appears as if ubiquitination of, rather than sumoylation of, PCNA contributes to the observed spontaneous mutator phenotype associated with proteasomal defects (McIntyre et al., 2006) . An important role for sumoylation of PCNA seems to be in preventing unscheduled HR during S-phase (Papouli et al., 2005; Pfander et al., 2005) . Nevertheless, recent studies suggest that PCNA sumoylation may be required for the stimulation of TLS in addition to the presence of monoubiquitinated PCNA (Halas et al., 2011) . In the case of PCNA, SUMO and ubiquitin appear to cooperatively rather than competitively coordinate the choice in DNA repair pathways of replication lesions (Plosky et al., 2006) .
Fanconi anemia
Fanconi anemia (FA) is a rare autosomal recessive and X-linked genetic disorder characterized in part by congenital deformities, bone marrow failure, and elevated risk of cancer. FA is associated with hypersensitivity to DNA crosslinking agents, and treatment of FA cells with such agents (mitomycin C, for example) leads to chromosomal instability and cell death (Heinrich et al., 2000) . 13 FA complementation groups have been identified (FANCA, B, C, D1, D2, E, F, G, I, J, L, M, and N) , and disruption of any one of the genes named after these complementation groups causes FA. Proposed roles for the FA pathway include involvement in circumventing stalled replication forks, HR, TLS, enzymatic DNA processing, and cell-cycle regulation (Kennedy & D'Andrea, 2005; Pang & Andreassen, 2009; Kratz et al., 2010) .
Fanconi anemia and DNA repair
At least 8 of the FA complementation groups (FANCA, B, C, E, F, G, L, and M) and two associated proteins, FAAP24 and FAAP100, form an E3 enzyme complex required for monoubiquitination of FANCD2 (Ciccia et al., 2007; Ling et al., 2007) . Loss of any subunit of this FA core complex negatively alters complex formation and prevents FANCD2 monoubiquitination . Specifically, monoubiquitination of FANCD2 occurs at K561 during S-phase during normal cell-cycle progression as well as following DNA damage (Kennedy & D'Andrea, 2005) . The latter event is linked to FANCD2 localization to chromatin and colocalization with other DNA damage signalling proteins such as FANCD1, Brca2, Rad51, Nbs1, and PCNA (Kennedy & D'Andrea, 2005; Nijman et al., 2005) . FANCL is capable of autoubiquitination in vitro and is required for monoubiquitination of FANCD2 and its relocation to damage-associated nuclear foci, suggesting that FANCL is the catalytic component of the FA core complex (Meetei et al., 2003; . Brca1 has the potential to serve as an E3 enzyme for FANCD2 in vitro, but genetic evidence hints that Brca1 is not required for FANCD2 monoubiquitination (Vandenberg et al., 2003) . Instead, Brca1 may modulate monoubiquitination of FANCD2 or the stability of the modified protein (Meetei et al., 2003) . UBE2T, which directly binds FANCL, is the E2 enzyme involved in monoubiquitination of FANCD2 (Machida et al., 2006) . UBE2T engages in a negative feedback loop, commencing self-inactivation by automonoubiquitination in vivo (Machida et al., 2006) . RPA1 and ATR are required for efficient FANCD2 monoubiquitination, and ATM is not necessary in this process (Andreassen et al., 2004) . Similarly, silencing of ATR, but not of ATM, suppresses FANCD2 foci formation following exposure of cells to DNA crosslinking agents (Andreassen et al., 2004) . As with PCNA, the DUB Usp1 associates with and regulates monoubiquitination of FANCD2, and Usp1 inhibition increases FANCD2 monoubiquitination (Nijman et al., 2005) . FANCD2 and FANCI share sequence homology (Smogorzewska et al., 2007) . Small interfering RNAs (siRNAs) directed against FANCD2, FANCI, and FANCA suppress HR, suggesting a role of these proteins in the DSB repair pathway. Like FANCD2, FANCI is ubiquitinated following DNA damage or during normal S-phase. These two enzymes form a complex, known as ID, which dictates FANCD2 localization in damage-associated nuclear foci. FANCD2 and FANCI are interdependent in that ubiquitin modification of each protein is dependent upon ubiquitin modification of the other (Smogorzewska et al., 2007) . FANCI also restricts monoubiquitination of FANCD2 to the correct lysine residue in vivo (Alpi et al., 2008) . FANCD2-ubiquitin and FANCD2-histone H2B fusion proteins harbouring an arginine substitution to remove the monoubiquitin site of FANCD2 have been shown to colocalize to chromatin and to reverse DNA-crosslink hypersensitivity of FANCD2-deficient cells (Matsushita et al., 2005) . However, these fusion proteins do not complement FANCC-, FANCG-, or FANCL-deficient cells, suggesting that the members of the FA core complex play roles outside that of monoubiquitination and chromatin targeting of FANCD2 (Matsushita et al., 2005) . The link between monoubiquitination of FANCD2/FANCI and recruitment of the ID complex to chromatin remains unclear (Al-Hakim et al., 2010) . Recent findings surrounding the FANCD2-associated nuclease KIAA1018/FAN1 provide valuable information regarding the functional importance of ID complex ubiquitination. FAN1 is a conserved protein with an N-terminal ubiquitin-binding zinc finger (UBZ) and a C-terminal nuclease domain (Kratz et al., 2010; Liu et al., 2010; MacKay et al., 2010; Smogorzewska et al., 2010) . FAN1 interacts with FANCD2 and FANCI, and loss of FAN1 is associated with hypersensitivity to and defective repair of intrastrand crosslinks. The UBZ of FAN1 targets the protein to damage-induced nuclear foci since deletion of the UBZ prevents FAN1 from accumulating at sites of damage (Kratz et al., 2010; Liu et al., 2010; MacKay et al., 2010; Smogorzewska et al., 2010) . Importantly, this recruitment of FAN1 is dependent upon interaction of its UBZ domain with monoubiquitinated FANCD2. Although the mechanism of FAN1 is still being elucidated, it will be interesting to determine whether other factors which also recognize ID complex monoubiquitination are recruited to sites of damage by crosslinking agents (Al-Hakim et al., 2010).
Proteasome inhibitors and DNA repair
Proteasome inhibitors include synthetic molecules and natural products (Groll et al., 2009 ). Most small molecule proteasome inhibitors are peptide derivatives that bind to the proteolytic active sites of the 20S proteasome (Huang & Chen, 2009 ). Specifically, bortezomib (PS-341, Velcade) is a dipeptidyl boric acid that selectively and reversibly inhibits the 5-subunit of the 20S with high affinity (Berkers et al., 2005) . Clinically, bortezomib administration results in tumor shrinkage through events such as cellular growth arrest, increased apoptosis, and decreased angiogenesis (Russo et al., 2007; Gilardini et al., 2008) . The mechanisms by which bortezomib exerts its effects, however, remain controversial. It has been shown that bortezomib stabilizes p21, p27, p53, proapoptotic proteins such as Bid and Bax, and the transcription factor Myc (McConkey & Zhu, 2008; Orlowski & Kuhn, 2008) . Inhibition of NF-B and of anti-apoptotic proteins, generation of reactive oxygen species (ROS), and increases in endoplasmic reticulum (ER) stress have also been implicated by some and repudiated by others as potential bortezomib-stimulated outcomes . Nevertheless, although the exact mechanisms of bortezomibinduced cell death remain inconclusive, current research hints at a role of DNA repair in this process. Bortezomib has been shown to enhance the DNA damage response. In a genome-wide siRNA screen to identify genetic components linked to bortezomib-induced cell death, knockdown of proteins responsible for HR was found to be protective against cell death www.intechopen.com
The Ubiquitin-Proteasome System and DNA Repair 271 . Bortezomib treatment leads to stabilization of Rad51, upregulation of ATM-dependant phosphorylation of H2AFX, CHK2, SMC1A, and TP53 and of ATRdependent phosphorylation of CHK1, as well as increased monoubiquitination of FANCD2 . Bortezomib has also been shown to inhibit basal and DNA damageinduced monoubiquitination of FANCD2 but not of PCNA (Jacquemont & Taniguchi, 2007) . A phase 3 clinical trial of bortezomib with melphalan and prednisone, the standard treatment of multiple myeloma patients, is currently ongoing with patients who cannot receive high-dose therapy San Miguel et al., 2008) . HR and FA are thought to be required for resistance to melphalan, a chemotherapeutic DNA alkylating agent, and bortezomib plus melphalan and prednisone produces outcomes greater than melphalanprednisone alone (Wang et al., 2001; Chen et al., 2005) . Since bortezomib appears to interfere with DNA-damage signaling, sensitization of cancer cells to melphalan and prednisone coud be due to the influence of the proteasome on one or more DNA repair pathway(s). Treatment of cells first with ionizing radiation or DNA crosslinking agents and secondly with bortezomib delays formation of phospho-ATM, 53BP1, Nbs1, and Brca1 foci and inhibits formation of FANCD2 and Rad51 foci. However, -H2AX, MDC1, and RPA foci are unaffected by these treatments, suggesting that early DNA damage signaling remains intact in these cells. This and similar results found using the proteasome inhibitors MG132 and epoxomicin (Jacquemont & Taniguchi, 2007; Takeshita et al., 2009 ) again suggest the requirement for UPS in DNA repair progression.
Conclusion
Here, we have summarized some of the current understanding of the relation of UPS to NER, BER, MMR, DSB, PRR, and FA repair. However, the influence of the UPS on DNA repair is not restricted to these repair mechanisms, as evidence suggests that the UPS also affects pathways beyond the scope of this review, such as direct repair by MGMT (O 6methylguanine-DNA methyltransferase) (Vlachostergios et al., 2009a) . Much evidence shows that the UPS is a potent regulator of repair following DNA damage. It will no doubt be interesting and beneficial to expand our knowledge of the UPS and DNA repair by using proteasome inhibitors such as bortezomib in conjunction with different chemotherapeutic and irradiation treatments. The obligatory cooperation between DNA repair and UPS is clearly preserved throughout eukaryotic evolution (Daulny & Tansey, 2009 ); upon consideration, this is a very logical example of the interdependence of seemingly disparate biological systems. Sequential enzymatic activity is a hallmark of well-regulated biological processes. In DNA repair, it appears in many cases that replacement of one enzyme with another depends on its tightly regulated proteolysis or other UPS-mediated modification (Hardeland et al., 2002a; Steinacher & Schar, 2005a; Parsons et al., 2008a) . The UPS has the necessary degree of control to execute the proteolysis in a manner required, enabling the repair processes to advance through different stages. A well-orchestrated activity of the two processes suggests that DNA repair and the UPS have co-evolved to provide living organisms with a way to cope with environmental DNA injuries. Increasingly complex UPS-mediated regulation of multifunctional repair enzymes such as PCNA, coinciding with evolution of higher eukaryotes, further supports this notion. It is interesting to note that DNA repair in prokaryotes, where there is no proteasome system, is regulated predominantly at the transcriptional level (Friedberg, 1996) . This regulation often involves the removal of a single protein (a transcriptional repressor), which allows for a particular operon to be expressed. In eukaryotes, while there are a few DNA repair proteins that are transcriptionally regulated (for example, PCNA and DNA polymerase most DNA repair is regulated at the level of post-translational modifications such as phosphorylation, acetylation, protein complex formation, as well as monoubiquitination, polyubiquitination, sumoylation, etc. (Vlachostergios et al., 2009b; Vlachostergios et al., 2009a) . The removal of specific proteins is needed for the DNA repair process progression in eukaryotic cells, but this removal in eukaryotes is more complex than the repressor system of DNA repair regulation prokaryotes-it requires the complex UPS to regulate protein accumulation and turnover (Motegi et al., 2009) . It is possible that the expansion of the eukaryotic genome to contain large numbers genes on several chromosomes made it necessary for proteasome complexes to co-exist and control DNA repair protein quantities at the level of protein degradation.
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